[Comparison of the antiarrhythmic action of ajmaline, N-n-propylajmalinehydrogen-tartrate and 4-[3'-diethylamino-2'-hydroxypropyl]-ajmalinehydrogentartrate (Tachmalcor) with their hemodynamic and cardiac side-effects].
D000157:Aconitine; D000404:Ajmaline / Q000009:adverse effects / Q000031:analogs & derivatives / Q000494:pharmacology*; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects / Q000494:pharmacology*; D001281:Atrial Fibrillation / Q000188:drug therapy; D001282:Atrial Flutter / Q000188:drug therapy; D001794:Blood Pressure / Q000187:drug effects; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004353:Drug Evaluation, Preclinical; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D007263:Infusions, Parenteral; D014655:Vascular Resistance / Q000187:drug effects
D000889:Anti-Arrhythmia Agents; D000404:Ajmaline; D000157:Aconitine
Vergleich der antiarrhythmischen Wirkung mit den hämodynamischen und kardialen Nebenwirkungen von Ajmalin, N-n-Propylajmalinhydrogen-tartrat und 4-[3'-Diäthylamino-2'-hydroxypropyl]-ajmalinhydrogentartrat (Tachmalcor)